By leading the manuscript development, Veranex supported Philips Healthcare in publishing real-world evidence data supporting the use of Mobile Cardiac Monitoring after a TAVR procedure.[dpvfw_pdf_viewer_embed _builder_version="4.18.0" _module_preset="default"...
Demonstrating Clinical Utility Using a Validated Methodology From the Market Research Toolkit
Veranex Director Lauren Fusfeld uses a case study to show how conjoint analysis can demonstrate to payers and health care providers the clinical utility of a prognostic test. Lauren's article is featured on page 30.
Recent Study Co-authored by Veranex Staff Highlights Cost-effectiveness of Home Non-invasive Ventilation in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom
By developing a cost-effectiveness model and associated manuscript for home non-invasive ventilation in patients with persistent hypercapnia after an acute exacerbation of COPD, Veranex bolstered the economic argument for home non-invasive ventilation in the UK. The...
Veranex Voices Ep 1 – It’s not just a label
Our Veranex Voices Series features our many subject matter experts to address issues to overcome when innovating for healthcare. Our hosts Talitha Brenninkmeyer, Rae Davel, and David Copeland sit down with Susan McDonald and Jimmy Wong to talk about labeling and it's...
Veranex Voices EP 2 – Don’t Wait: Set Up Success with early integration of human factors
Our Veranex Voices Series features our many subject matter experts to address issues to overcome when innovating for healthcare. Our hosts Talitha Brenninkmeyer, Rae Davel, and David Copeland sit down with Susan McDonald and Jimmy Wong to talk about the importance of...